Trial intelligence / Profile preview

Bioequivalence study of Mirtazapine ODT 30 mg vs Remeron SolTab 30 mg in healthy Thai volunteers under fasting conditions

TCTR20240427006Phase 1Unknown

Sponsor
Bio-innova
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of mirtazapine (2 arms), sponsored by Bio-innova. Status: unknown.

02

Drugs

mirtazapine

Beyond the preview

Go deeper on TCTR20240427006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240427006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call